USA Financial Formulas Has $1.42 Million Stock Holdings in Lam Research Corporation $LRCX

USA Financial Formulas reduced its stake in shares of Lam Research Corporation (NASDAQ:LRCX) by 37.0% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 6,639 shares of the semiconductor company’s stock after selling 3,900 shares during the period. Lam Research makes up approximately 0.3% of USA Financial Formulas’ holdings, making the stock its 21st biggest holding. USA Financial Formulas’ holdings in Lam Research were worth $1,418,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of LRCX. Brighton Jones LLC increased its position in shares of Lam Research by 1,032.4% during the fourth quarter. Brighton Jones LLC now owns 14,189 shares of the semiconductor company’s stock worth $1,025,000 after acquiring an additional 12,936 shares in the last quarter. Caxton Associates LLP bought a new stake in Lam Research in the 1st quarter valued at $239,000. Gabelli Funds LLC bought a new stake in Lam Research in the 2nd quarter valued at $253,000. NewEdge Advisors LLC boosted its stake in Lam Research by 2.7% in the 2nd quarter. NewEdge Advisors LLC now owns 100,528 shares of the semiconductor company’s stock worth $9,785,000 after purchasing an additional 2,661 shares during the period. Finally, Osterweis Capital Management Inc. boosted its stake in Lam Research by 5,206.7% in the 2nd quarter. Osterweis Capital Management Inc. now owns 796 shares of the semiconductor company’s stock worth $77,000 after purchasing an additional 781 shares during the period. Institutional investors own 84.61% of the company’s stock.

Analysts Set New Price Targets

Several research firms have issued reports on LRCX. Wall Street Zen downgraded Lam Research from a “buy” rating to a “hold” rating in a research note on Sunday, May 10th. Bank of America upped their price objective on Lam Research from $330.00 to $480.00 and gave the stock a “buy” rating in a research report on Tuesday, June 23rd. Raymond James Financial set a $425.00 price objective on Lam Research in a report on Wednesday, June 10th. UBS Group reissued a “buy” rating and issued a $375.00 target price (up from $310.00) on shares of Lam Research in a research report on Tuesday, June 9th. Finally, Susquehanna restated a “positive” rating and issued a $475.00 target price (up from $385.00) on shares of Lam Research in a research note on Tuesday, June 30th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $358.47.

Lam Research Price Performance

Shares of NASDAQ LRCX opened at $310.17 on Tuesday. The stock has a market capitalization of $388.12 billion, a price-to-earnings ratio of 53.85, a PEG ratio of 1.25 and a beta of 1.84. The business has a 50-day moving average of $335.90 and a 200-day moving average of $286.99. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.63 and a quick ratio of 1.91. Lam Research Corporation has a fifty-two week low of $94.11 and a fifty-two week high of $438.50.

Lam Research (NASDAQ:LRCX) last released its earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.69 by $0.13. Lam Research had a return on equity of 67.60% and a net margin of 31.27%.The business had revenue of $6.72 billion for the quarter, compared to analyst estimates of $6.66 billion. During the same quarter in the prior year, the company posted $1.33 earnings per share. Lam Research’s revenue was up 30.0% on a year-over-year basis. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. As a group, sell-side analysts predict that Lam Research Corporation will post 9.32 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, SVP Neil J. Fernandes sold 7,659 shares of the stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $309.60, for a total value of $2,371,226.40. Following the completion of the sale, the senior vice president owned 58,470 shares of the company’s stock, valued at approximately $18,102,312. This represents a 11.58% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Eric Brandt sold 54,500 shares of the firm’s stock in a transaction on Thursday, June 11th. The shares were sold at an average price of $350.80, for a total transaction of $19,118,600.00. Following the completion of the transaction, the director directly owned 199,205 shares of the company’s stock, valued at $69,881,114. This represents a 21.48% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 80,441 shares of company stock valued at $27,614,296 in the last 90 days. 0.31% of the stock is currently owned by insiders.

Lam Research Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.